BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18477844)

  • 1. Thrombolysis in capsular warning syndrome.
    Vivanco-Hidalgo RM; Rodriguez-Campello A; Ois A; Cucurella G; Pont-Sunyer C; Gomis M; Cuadrado-Godia E; Roquer J
    Cerebrovasc Dis; 2008; 25(5):508-10. PubMed ID: 18477844
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolysis in capsular warning syndrome].
    González Hernández A; Fabre Pi O; López Fernández JC; Díaz Nicolás S
    Med Clin (Barc); 2010 May; 134(13):612-3. PubMed ID: 19359006
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
    Marrone LC; Marrone AC
    Cerebrovasc Dis; 2012; 34(3):246-7. PubMed ID: 23018342
    [No Abstract]   [Full Text] [Related]  

  • 4. TPA for acute ischemic stroke.
    Fischer J
    S D J Med; 1997 Feb; 50(2):69-70. PubMed ID: 9062450
    [No Abstract]   [Full Text] [Related]  

  • 5. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
    Flaherty ML; Kissela B; Khatri P
    Neurology; 2007 Feb; 68(9):710-1; author reply 711. PubMed ID: 17328117
    [No Abstract]   [Full Text] [Related]  

  • 6. Mortality of stroke patients treated with thrombolysis: analysis of nationwide inpatient sample.
    Kurth T; Heuschmann PU; Walker AM; Berger K
    Neurology; 2007 Feb; 68(9):710; author reply 711. PubMed ID: 17325289
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 8. Is hospitalization after TIA cost-effective on the basis of treatment with tPA?
    Nguyen-Huynh MN; Johnston SC
    Neurology; 2005 Dec; 65(11):1799-801. PubMed ID: 16344525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator for transient ischemic attack: the case for "off-label" use of thrombolytics.
    Sobel RM; Wu DT; Hester K; Anda K
    Am J Emerg Med; 2014 Mar; 32(3):277-9. PubMed ID: 24377761
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical MRI markers in transient ischemic attack.
    Ritzenthaler T; Cho TH; Louis-Tisserand G; Berthezene Y; Nighoghossian N
    Neurol Sci; 2015 Oct; 36(10):1957-9. PubMed ID: 26152798
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Manco-Johnson MJ; Grabowski EF; Hellgreen M; Kemahli AS; Massicotte MP; Muntean W; Peters M; Schlegel N; Wang M; Nowak-Göttl U
    Thromb Haemost; 2002 Jul; 88(1):157-8. PubMed ID: 12152658
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombolytic therapy of cerebral infarction using alteplase--the Helsinki model].
    Lindsberg PJ; Soinne L; Roine RO; Salonen O; Tatlisumak T; Kallela M; Häppölä O; Tiainen M; Haapaniemi E; Kuisma M; Kaste M
    Duodecim; 2003; 119(18):1723-9. PubMed ID: 14587458
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A; Dzialowski I; Koch R; Gahn G
    J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
    Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
    Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator does not benefit most eligible patients with stroke.
    Lansberg MG; Schwartz NE
    Arch Neurol; 2009 Apr; 66(4):540-1; author reply 541. PubMed ID: 19364946
    [No Abstract]   [Full Text] [Related]  

  • 17. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital.
    van den Berg JS; de Jong G
    Acta Neurol Scand; 2009 Sep; 120(3):157-60. PubMed ID: 19719807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.
    Hattenbach LO; Kuhli-Hattenbach C; Scharrer I; Baatz H
    Am J Ophthalmol; 2008 Nov; 146(5):700-6. PubMed ID: 18718570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic treatment of acute pulmonary embolism in myotonic dystrophy.
    Jabr FI
    J Emerg Med; 2006 Feb; 30(2):220-1. PubMed ID: 16567263
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytic therapy in brain infarction after ECASS II study].
    Kaste M
    Duodecim; 1998; 22(114):2291-2. PubMed ID: 11757089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.